feed,title,long_url,short_url
Benzinga,Genomics in Cancer Care Market is estimated to be US$ 72.61 billion by 2032 with a CAGR of 16.3% during the forecast period 2032 - By PMI,https://benzinga.com/pressreleases/22/10/g29216229/genomics-in-cancer-care-market-is-estimated-to-be-us-72-61-billion-by-2032-with-a-cagr-of-16-3-dur,
